NIH Scientist’s Decoy Virus Revolutionizes Cervical Cancer Prevention
By Melissa Glim
Monday, March 1, 2021
The National Academy of Sciences (NAS), established in 1863, is comprised of the United States’ most distinguished scientific scholars, including nearly 500 Nobel Prize winners. Members of the NAS are elected by their peers and entrusted with the responsibility of providing independent, objective advice on national matters related to science and technology in an effort to advance innovations in the United States.
IRP senior investigator John T. Schiller, Ph.D., was elected to the NAS in 2020 in recognition of a career that has produced numerous discoveries about human papillomaviruses (HPV), sexually transmitted infections that cause genital warts and are responsible for most cases of cervical cancer. His decades-long partnership with fellow IRP senior investigator Douglas R. Lowy, M.D., who was elected to the NAS in 2009, has yielded a deeper understanding of how HPV infects and damages cells and led to the creation of the first vaccines to prevent HPV infection.
Custom-Built Molecule May Improve On Its Natural Counterpart
By Melissa Glim
Monday, February 22, 2021
Ten years ago, a young woman from Chicago came to the National Institutes of Health with a rare genetic condition. A mutation in her DNA was making her metabolic system malfunction, causing levels of fat molecules called triglycerides in her blood to skyrocket far out of the normal range. This triggered inflammation in her pancreas, a painful and potentially life-threatening condition known as pancreatitis. She couldn’t understand why there wasn’t any kind of treatment to help her.
IRP senior investigator Alan T. Remaley, M.D., Ph.D., took on the challenge with the help of Anna Wolska, Ph.D., a research fellow in his lab. Dr. Remaley leads the Lipoprotein Metabolism Section in the National Heart, Lung, and Blood Institute (NHLBI), where he and Dr. Wolska study lipoproteins, small particles that transport fats such as cholesterol and triglycerides through the bloodstream to be broken down and used by cells for energy. Their efforts to help that young woman ultimately led to the discovery — published last January — of a new strategy for reducing triglycerides in order to treat serious ailments like pancreatitis and heart disease.
Artificial Intelligence Simplifies Cervical Cancer Screening
By Melissa Glim
Wednesday, January 27, 2021
Even though cervical cancer is considered one of the most preventable forms of cancer, it remains a serious and deadly scourge for many across the world. A computer algorithm designed to quickly and easily identify pre-cancerous changes using a regular smartphone may change that.
“The point of everything that we do and have done in the last 40 years is to understand something deeply so that we can invent simple tools to use,” says IRP senior investigator, Mark Schiffman, M.D., M.P.H. To that end, he and collaborators in the National Cancer Institute (NCI) and the National Library of Medicine (NLM), in collaboration with the Global Health Labs and Unitaid, developed and are now testing a machine learning-based approach to screening for cervical cancer, with promising results.
NIH Researcher Recognized for Contributions to Structural Biology Techniques
By Melissa Glim
Tuesday, January 19, 2021
The National Academy of Sciences (NAS), established in 1863, is comprised of the United States’ most distinguished scientific scholars, including nearly 500 Nobel Prize winners. Members of the NAS are elected by their peers and entrusted with the responsibility of providing independent, objective advice on national matters related to science and technology in an effort to advance innovations in the United States.
IRP senior investigator Robert Tycko, Ph.D., was one of two NIH researchers elected to the NAS in 2020, an honor he hopes will give him the opportunity to help other scientists and improve the way science is done.
NIH Researcher’s Pioneering Work Led to Discovery of Hepatitis C
By Melissa Glim
Monday, January 11, 2021
When the phone rang at 4:15 in the morning, IRP senior scientist Harvey J. Alter, M.D., was annoyed. He didn’t answer it. After the third try, he reluctantly got out of bed and took his phone out to the hallway.
“Before I could yell at the person, he said, ‘This is Stockholm calling,’” Dr. Alter recalls. “And then I got stopped in my tracks. Then the moment of disbelief and awe comes over you.”
The man from Stockholm informed Dr. Alter that he had won the 2020 Nobel Prize in Physiology or Medicine for his contributions to the discovery of the hepatitis C virus. He shared the prize with Michael Houghton, Ph.D., of the University of Alberta, Canada, and Charles M. Rice, Ph.D., of Rockefeller University in New York.
Sugar Molecule Protects Mice Against Type 1 Diabetes
By Melissa Glim
Monday, November 23, 2020
Avoiding too much sugar is one of the cardinal rules for those who have or are at risk for diabetes. In fact, diabetes is characterized by having too much glucose, a form of sugar, in the blood. As a result, it came as quite a surprise to IRP researchers led by senior investigator Wanjun Chen, M.D., when they discovered that a particular form of sugar that they expected to have no effect on diabetes-prone mice actually protected them from developing type 1 diabetes.
NIH Researcher Recognized for Advances in Brain Imaging
By Melissa Glim
Tuesday, November 17, 2020
The National Academy of Engineering (NAE), established in 1964, comprises more than 2,000 peer-elected members who are among the world’s most accomplished engineers, including senior professionals in business, academia, and government.
IRP senior investigator Peter Basser, Ph.D., was elected to the NAE in February 2020. He directs the Section on Quantitative Imaging and Tissue Science and the Division of Translational Imaging and Genomic Integrity in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), where he studies how the structure and material properties of living tissues affect their function.
Genetic Studies Illuminate Neuronal Chemical’s Role in Pain and Itch
By Melissa Glim
Thursday, October 29, 2020
For most of us, itch is a bothersome inconvenience. Unfortunately, for 125 million people around the world, chronic itch caused by the skin disease psoriasis is a significant, even debilitating, health problem. Psoriasis causes skin cells to multiply up to 10 times faster than normal and build up as an itchy and painful, scaly rash. For some, the condition can also cause joint swelling, resulting in a condition known as ‘psoriatic arthritis.’
World Psoriasis Day falls on October 29 this year, and the theme is “Be Informed.” So, what do we know about chronic itch?
NIH Researcher Recognized for Investigation into the Skin Microbiome
By Melissa Glim
Tuesday, October 27, 2020
The National Academy of Medicine (NAM), first established in 1970 by the National Academy of Sciences as the Institute of Medicine (IOM), is comprised of more than 2,000 elected members from around the world who provide scientific and policy guidance on important matters relating to human health. Election to the NAM is considered one of the highest honors in the fields of health and medicine that recognizes individuals who have not only made critical scientific discoveries but have also demonstrated a laudable commitment to public service.
IRP senior investigator Julie Segre, Ph.D., was one of four IRP researchers elected to the NAM in 2019. Dr. Segre leads the Translational and Functional Genomics Branch at the National Human Genome Research Institute (NHGRI), where she studies the way in which the skin forms a barrier between the body and the environment. In particular, her research uses genetic sequencing to understand the bacterial and fungal microbes that live on human skin.